Vimirogant

(Synonyms: VTP-43742)
1 Cited Publications
Customer Review

Based on 1 publication(s) in Google Scholar

Vimirogant (VTP-43742) is a potent, selective, and orally active RORγt inhibitor with a Ki of 3.5 nM for binding to RORγt. VTP-43742 blocks Th17 cell differentiation and reduces IL-17A production by inhibiting RORγt-mediated transcriptional activity, thereby suppressing the RORγt/Th17/IL-17 inflammatory axis. VTP-43742 can be used for research on autoimmune diseases and inflammation-related diseases.

The free form of the compound is prone to instability, it is advisable to consider the stable salt form (Vimirogant hydrochloride) that retains the same biological activity.

For research use only. We do not sell to patients.

  • CAS No.: 1802706-04-2
  • Formula: C27H35F3N4O3S
  • Molecular Weight:552.65
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Protocols
  • Purity & Documentation
  • References
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) Vimirogant

More

All ROR Isoforms

More
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00